Utility of biochemical markers in the follow-up of heart transplant recipients

A. Balduini, C. Campana, M. Ceresa, E. Arbustini, T. Bosoni, A. Serio, C. Tinelli, M. Viganò, G. L. Melzi D'Eril, L. Tavazzi, R. Moratti, G. Merlini

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. However, considering the potential complications of this procedure, a noninvasive marker of rejection would be an ideal alternative or at least a helpful adjunct to posttransplant management. We measured myoglobin (Myo), creatine kinase MB mass (CK-MBm), troponin T (cTnT), serum amyloid A (SAA), and C-reactive protein (CRP) in 57 patients (mean age 37.5 years) who underwent orthotopic heart transplantation for end-stage cardiac failure between January and December 2001. Endomyocardial biopsies were performed routinely after surgery and histologically diagnosed rejection was graded according to the criteria of the International Society of Heart and Lung Transplantation. Concomittant with the biopsies, blood samples were drawn from the coronary sinus (central blood samples) and from a peripheral vein (peripheral blood samples) to assay biochemical markers. Among 149 EMB evaluated, 87 were negative (grade 0); 28 showed grade 1a rejection; 26 showed grade 1b; and 8 showed grade > 1b (2 were grade 2, 6 were grade 3a). Grades 0 and 1a were considered to be negative, while grades 1b and >1b were considered positive indicating potential acute graft rejection. cTnT, Myo, CK-MBm, SAA, and CRP levels were measured in 149 central blood samples and 149 peripheral blood samples. Myo and CK-MBm did not show significant changes. cTnT seems to be a potentially useful addition to the EMB results, while SAA and CRP showed variations with respect to EMB grade both in central and peripheral samples.

Original languageEnglish
Pages (from-to)3075-3078
Number of pages4
JournalTransplantation Proceedings
Volume35
Issue number8
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Biomarkers
Biopsy
Serum Amyloid A Protein
MB Form Creatine Kinase
Troponin T
Myoglobin
C-Reactive Protein
Graft Rejection
Heart-Lung Transplantation
Coronary Sinus
Heart Transplantation
Transplant Recipients
Veins
Heart Failure

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Utility of biochemical markers in the follow-up of heart transplant recipients. / Balduini, A.; Campana, C.; Ceresa, M.; Arbustini, E.; Bosoni, T.; Serio, A.; Tinelli, C.; Viganò, M.; Melzi D'Eril, G. L.; Tavazzi, L.; Moratti, R.; Merlini, G.

In: Transplantation Proceedings, Vol. 35, No. 8, 12.2003, p. 3075-3078.

Research output: Contribution to journalArticle

Balduini, A. ; Campana, C. ; Ceresa, M. ; Arbustini, E. ; Bosoni, T. ; Serio, A. ; Tinelli, C. ; Viganò, M. ; Melzi D'Eril, G. L. ; Tavazzi, L. ; Moratti, R. ; Merlini, G. / Utility of biochemical markers in the follow-up of heart transplant recipients. In: Transplantation Proceedings. 2003 ; Vol. 35, No. 8. pp. 3075-3078.
@article{14995304746147cdb902345b7d877e7e,
title = "Utility of biochemical markers in the follow-up of heart transplant recipients",
abstract = "Endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. However, considering the potential complications of this procedure, a noninvasive marker of rejection would be an ideal alternative or at least a helpful adjunct to posttransplant management. We measured myoglobin (Myo), creatine kinase MB mass (CK-MBm), troponin T (cTnT), serum amyloid A (SAA), and C-reactive protein (CRP) in 57 patients (mean age 37.5 years) who underwent orthotopic heart transplantation for end-stage cardiac failure between January and December 2001. Endomyocardial biopsies were performed routinely after surgery and histologically diagnosed rejection was graded according to the criteria of the International Society of Heart and Lung Transplantation. Concomittant with the biopsies, blood samples were drawn from the coronary sinus (central blood samples) and from a peripheral vein (peripheral blood samples) to assay biochemical markers. Among 149 EMB evaluated, 87 were negative (grade 0); 28 showed grade 1a rejection; 26 showed grade 1b; and 8 showed grade > 1b (2 were grade 2, 6 were grade 3a). Grades 0 and 1a were considered to be negative, while grades 1b and >1b were considered positive indicating potential acute graft rejection. cTnT, Myo, CK-MBm, SAA, and CRP levels were measured in 149 central blood samples and 149 peripheral blood samples. Myo and CK-MBm did not show significant changes. cTnT seems to be a potentially useful addition to the EMB results, while SAA and CRP showed variations with respect to EMB grade both in central and peripheral samples.",
author = "A. Balduini and C. Campana and M. Ceresa and E. Arbustini and T. Bosoni and A. Serio and C. Tinelli and M. Vigan{\`o} and {Melzi D'Eril}, {G. L.} and L. Tavazzi and R. Moratti and G. Merlini",
year = "2003",
month = "12",
doi = "10.1016/j.transproceed.2003.10.044",
language = "English",
volume = "35",
pages = "3075--3078",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Utility of biochemical markers in the follow-up of heart transplant recipients

AU - Balduini, A.

AU - Campana, C.

AU - Ceresa, M.

AU - Arbustini, E.

AU - Bosoni, T.

AU - Serio, A.

AU - Tinelli, C.

AU - Viganò, M.

AU - Melzi D'Eril, G. L.

AU - Tavazzi, L.

AU - Moratti, R.

AU - Merlini, G.

PY - 2003/12

Y1 - 2003/12

N2 - Endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. However, considering the potential complications of this procedure, a noninvasive marker of rejection would be an ideal alternative or at least a helpful adjunct to posttransplant management. We measured myoglobin (Myo), creatine kinase MB mass (CK-MBm), troponin T (cTnT), serum amyloid A (SAA), and C-reactive protein (CRP) in 57 patients (mean age 37.5 years) who underwent orthotopic heart transplantation for end-stage cardiac failure between January and December 2001. Endomyocardial biopsies were performed routinely after surgery and histologically diagnosed rejection was graded according to the criteria of the International Society of Heart and Lung Transplantation. Concomittant with the biopsies, blood samples were drawn from the coronary sinus (central blood samples) and from a peripheral vein (peripheral blood samples) to assay biochemical markers. Among 149 EMB evaluated, 87 were negative (grade 0); 28 showed grade 1a rejection; 26 showed grade 1b; and 8 showed grade > 1b (2 were grade 2, 6 were grade 3a). Grades 0 and 1a were considered to be negative, while grades 1b and >1b were considered positive indicating potential acute graft rejection. cTnT, Myo, CK-MBm, SAA, and CRP levels were measured in 149 central blood samples and 149 peripheral blood samples. Myo and CK-MBm did not show significant changes. cTnT seems to be a potentially useful addition to the EMB results, while SAA and CRP showed variations with respect to EMB grade both in central and peripheral samples.

AB - Endomyocardial biopsy (EMB) is currently the standard method to diagnose acute graft rejection. However, considering the potential complications of this procedure, a noninvasive marker of rejection would be an ideal alternative or at least a helpful adjunct to posttransplant management. We measured myoglobin (Myo), creatine kinase MB mass (CK-MBm), troponin T (cTnT), serum amyloid A (SAA), and C-reactive protein (CRP) in 57 patients (mean age 37.5 years) who underwent orthotopic heart transplantation for end-stage cardiac failure between January and December 2001. Endomyocardial biopsies were performed routinely after surgery and histologically diagnosed rejection was graded according to the criteria of the International Society of Heart and Lung Transplantation. Concomittant with the biopsies, blood samples were drawn from the coronary sinus (central blood samples) and from a peripheral vein (peripheral blood samples) to assay biochemical markers. Among 149 EMB evaluated, 87 were negative (grade 0); 28 showed grade 1a rejection; 26 showed grade 1b; and 8 showed grade > 1b (2 were grade 2, 6 were grade 3a). Grades 0 and 1a were considered to be negative, while grades 1b and >1b were considered positive indicating potential acute graft rejection. cTnT, Myo, CK-MBm, SAA, and CRP levels were measured in 149 central blood samples and 149 peripheral blood samples. Myo and CK-MBm did not show significant changes. cTnT seems to be a potentially useful addition to the EMB results, while SAA and CRP showed variations with respect to EMB grade both in central and peripheral samples.

UR - http://www.scopus.com/inward/record.url?scp=0347131305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347131305&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2003.10.044

DO - 10.1016/j.transproceed.2003.10.044

M3 - Article

C2 - 14697983

AN - SCOPUS:0347131305

VL - 35

SP - 3075

EP - 3078

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -